Pathogenic BRCA1 DBD variants exhibit altered DNA binding affinities and susceptibility to menadione
Authors:
- Emma CismasECEmma Cismas
- Esme LowryELEsme Lowry
- Vereena SalibVSVereena Salib
- Kaitlin LowranKLKaitlin Lowran
- Colin G. WuCWColin G. Wu
Preprint
Abstract
Breast Cancer Susceptibility Gene 1 ( BRCA1 ) codes for a DNA repair protein that facilitates the repair of double-stranded DNA breaks (DSBs) in human cells through the homologous recombination (HR) pathway. Mutations of BRCA1 are highly associated with breast cancer; however, many variants remain unclassified with unknown cellular phenotypes. The DNA binding activity of BRCA1 is localized primarily to its central region, which can be divided into two distinct domains: DNA Binding Domain 1 (DBD1; amino acids (aa) 330-554) and 2 (DBD2; aa 894-1057). We previously proposed a model in which DBD1 targets BRCA1 to DSBs for the promotion of DNA end resection, while DBD2 targets BRCA1 to telomeres to function in chromatin remodeling and telomere regulation. In this study, we hypothesized that unknown DBD variants (T374I, K408E, N417S, N909I, M1008I, and R1028H) with similar properties to known disease-causing variants (Q356H, F461L, R496H, D940Y, S1027N, and E1038G) would also be pathogenic. The affinities of each variant for single-stranded DNA (ssDNA), double-stranded DNA (dsDNA), and a G-quadruplex (G4) sequence were measured via biolayer interferometry. The DNA repair phenotypes of each variant were analyzed by overexpression in HEK cells to determine correlation between binding activity and DNA damage response. Altogether, these results provide insight into how missense mutations affect the ability of BRCA1 DBDs to facilitate the DNA damage response.Keywords
This publication has 52 references indexed in Scilit:
- Advancing the study of protein-G4 interactions in DNA repair: Insights from biolayer interferometry2024
- Revisiting the BRCA-pathway through the lens of replication gap suppressionDNA Repair, 2021
- Cardiovascular risk of BRCA1/2 mutation carriers: A reviewMaturitas, 2016
- Biochemical mechanism of DSB end resection and its regulationDNA Repair, 2015
- LOVD v.2.0: the next generation in gene variant databasesHuman Mutation, 2011
- The role of BRCA1 in DNA damage responseProtein & Cell, 2010
- Incorporating the amino acid properties to predict the significance of missense mutationsAmino Acids, 2008
- Natural selection and mammalian BRCA1 sequences: elucidating functionally important sites relevant to breast cancer susceptibility in humansMammalian Genome, 2006
- Characterization of Segments from the Central Region of BRCA1: An Intrinsically Disordered Scaffold for Multiple Protein–Protein and Protein–DNA Interactions?Journal of Molecular Biology, 2005
- Purification and Characterisation of a Soluble N-terminal Fragment of the Breast Cancer Susceptibility Protein BRCA1Journal of Molecular Biology, 2004